UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
BIOTRONIK announces CE mark for PK Papyrus covered coronary stent for acute coronary artery perforation
Date: Nov-08-2013BIOTRONIK has announced that the PK Papyrus covered coronary stent system has received CE mark for the treatment of acute coronary artery perforation. PK Papyrus boasts 58% greater flexibility than Abbott's Jostent Graftmaster due to its innovative "electrospun" membrane. The enhanced "electrospinning" technology allows for a proprietary singlelayer covered stent design, rather than the traditional "sandwich technique" used on comparable stents on the market...
Experts release landmark findings and recommendations on hepatitis C in African Americans
Date: Nov-08-2013The National Medical Association (NMA) today released the much anticipated Consensus Panel Paper entitled: Hepatitis C: A Crisis in the African American Community. The NMA is the nation's largest and oldest association of African American physicians and when faced with the startling facts on the burden of Hepatitis C (HCV) in the African American community; Immediate NMA Past President, Rahn K. Bailey, MD convened experts to make recommendations to address this crisis. Hepatitis C is a viral disease...
Moffitt Cancer Center recruiting healthy volunteers for "chemo brain" study
Date: Nov-08-2013Moffitt Cancer Center is recruiting healthy volunteers to participate in a study to determine quality-of-life changes in blood and marrow transplant patients. A blood and marrow transplant (BMT) involves replacing a patient's faulty stem cells with healthy ones. Leukemia patients commonly receive this procedure to replace stem cells damaged by the high doses of chemotherapy and radiation used to treat the disease. "Research suggests that approximately 40 percent of blood and marrow transplant patients demonstrate 'chemo brain,' or chemotherapy-related cognitive impairment...
Nail gun injuries on the rise in Australasia
Date: Nov-08-2013Young males in the work environment are at greatest risk of sustaining a nail gun injury to their non-dominant hand, a new study has found. Writing in the latest Early View issue of Emergency Medicine Australasia, the journal of the Australasian College for Emergency Medicine, Dr James Ling, Dr Natalie Ong, and Dr John North, all from Brisbane's Princess Alexandra Hospital, said nail guns are commonly used in the building and construction industry because they increase productivity and are technically easy to operate...
Why stem cells need to stick with their friends
Date: Nov-08-2013Scientists at University of Copenhagen and University of Edinburgh have identified a core set of functionally relevant factors which regulates embryonic stem cells' ability for self-renewal. A key aspect is the protein Oct4 and how it makes stem cells stick together. The identification of these factors will be an important tool in devising better and safer ways of making specialised cells for future regenerative cell therapies for treatment of diseases like diabetes and Parkinson's disease. The results have just been published in the scientific journal Current Biology...
Government cuts putting patients at risk of Clostridium difficile infection say experts, UK
Date: Nov-08-201372% of clinicians believe that Government spending cuts within the NHS increase the risk of hospital acquired infections.1 The 'Think C-differently' report, which advises on the current Clostridium difficile landscape, found that despite stringent measures to manage and control Clostridium difficile infection (CDI), the NHS is still battling to keep infection rates to a minimum...
"New" infectious diseases: Clinical tests on innovative Themis vaccine
Date: Nov-08-2013A vaccine against the dreaded Chikungunya fever, developed by Vienna-based biotech company Themis Bioscience, is now undergoing clinical testing for the first time. The vaccine, which is based on a standard anti-measles vaccine, offers a genuine opportunity to halt the spread of the disease, which was originally restricted to tropical countries. Due to a lack of vaccinations, the infection is now also becoming a growing threat to industrialized countries as a result of increased foreign travel...
"New" infectious diseases: Clinical tests on innovative Themis vaccine
Date: Nov-08-2013A vaccine against the dreaded Chikungunya fever, developed by Vienna-based biotech company Themis Bioscience, is now undergoing clinical testing for the first time. The vaccine, which is based on a standard anti-measles vaccine, offers a genuine opportunity to halt the spread of the disease, which was originally restricted to tropical countries. Due to a lack of vaccinations, the infection is now also becoming a growing threat to industrialized countries as a result of increased foreign travel...
RyMed Technologies emerges as victor in patent infringement case
Date: Nov-08-2013A federal judge has found in favor of RyMed Technologies and against ICU Medical (Nasdaq: ICUI) in a closely watched patent-infringement case concerning intravenous (IV) catheter safety technology. The judge ruled ICU Medical had failed to prove that RyMed's InVision-Plus® IV connector infringed a patent held by ICU Medical. "This new ruling is particularly significant, because it means that virtually all the patent infringement issues raised by ICU Medical have been decided in RyMed's favor," said Dana Wm. Ryan, President and CEO of RyMed Technologies...
Support of parents and peers vital for millennials leaving home
Date: Nov-08-2013Leaving home is an important milestone that signals entry into adulthood. But young people are staying home longer than ever before. In fact, the 2011 census report from Statistics Canada shows that 42.3 per cent of young adults aged 20 to 29 still lived with their parents - that's compared to 32.1 per cent in 1991, and 26.9 per cent in 1981. The diminishing number of blue-collar jobs, rising costs of housing and increasing need for prolonged postsecondary education have impacted how, when and why young adults leave home...
Stay Connected
